The Board of Directors of Icure Pharmaceutical Incorporation has authorized a buyback plan on February 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,650 KRW | +17.52% |
|
+10.42% | +26.79% |
1st Jan change | Capi. | |
---|---|---|
+26.79% | 71.49M | |
-11.24% | 233B | |
+17.07% | 19.7B | |
0.00% | 19.52B | |
+7.81% | 11.4B | |
-18.44% | 8.74B | |
+3.31% | 6.66B | |
-2.28% | 5.28B | |
-7.28% | 4B | |
-11.76% | 4.07B |
- Stock Market
- Equities
- A175250 Stock
- News Icure Pharmaceutical Incorporation
- Icure Pharmaceutical Incorporation authorizes a Buyback Plan.